Enlivex Insider Holdings: What Investors Should Watch for 2026Enlivex insider holdings reveal 3 % stake and options that may dilute shares upon clinical milestones – a steady‑risk profile for biotech investors.Enlivex Ltd Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 18/03/2026, 14:05 3 minutes to read
